These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25750765)

  • 61. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
    Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
    Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells.
    Li D; Cao W
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G863-72. PubMed ID: 24699332
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence.
    Ahmad J; Arthur K; Maxwell P; Kennedy A; Johnston BT; Murray L; McManus DT
    Dis Esophagus; 2015 Apr; 28(3):276-82. PubMed ID: 24612412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
    Liu FX; Wang WH; Wang J; Li J; Gao PP
    Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
    Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
    DE Carli DM; Araujo AF; Fagundes RB
    Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus.
    Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM
    J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
    Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
    Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
    Hardikar S; Onstad L; Blount PL; Odze RD; Reid BJ; Vaughan TL
    PLoS One; 2013; 8(1):e52192. PubMed ID: 23300966
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients.
    Freudenheim JL; Marshall JR; Vena JE; Laughlin R; Brasure JR; Swanson MK; Nemoto T; Graham S
    J Natl Cancer Inst; 1996 Mar; 88(6):340-8. PubMed ID: 8609642
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.
    Leeuwenburgh I; Scholten P; Caljé TJ; Vaessen RJ; Tilanus HW; Hansen BE; Kuipers EJ
    Dig Dis Sci; 2013 Jan; 58(1):244-52. PubMed ID: 23179142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma.
    Wong A; Fitzgerald RC
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):1-10. PubMed ID: 15645398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.
    Gatenby P; Caygill C; Wall C; Bhatacharjee S; Ramus J; Watson A; Winslet M
    World J Gastroenterol; 2014 Jul; 20(28):9611-7. PubMed ID: 25071359
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The role of selected risk factors in Barrett's esophagus development].
    Kiciński P; Mokrowiecka A; Czkwianianc E; Kolasa-Kicińska M; Wozniakowska-Gesicka T; Małecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):390-4. PubMed ID: 19606681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.